Literature DB >> 10728974

Molecular mapping of statherin- and histatin-binding domains in human salivary mucin MG1 (MUC5B) by the yeast two-hybrid system.

I Iontcheva1, F G Oppenheim, G D Offner, R F Troxler.   

Abstract

MGI is a high-molecular-weight mucin secreted by mucous acinar cells in human submandibular and sublingual glands. We have recently shown that the tracheobronchial mucin MUC5B is a major component of MG1. MUC5B is organized into cysteine-rich N- and C-terminal regions that flank a central tandem-repeat region containing cysteine-rich subdomains and imperfect 29-residue tandem repeats. In earlier work, we have shown that this mucin selectively forms heterotypic complexes with amylase, proline-rich proteins, statherin, and histatins in salivary secretions, and the aim of this study was to identify specific binding domains within MUC5B using the yeast two-hybrid system. Interactions of cysteine-rich domains in the tandem-repeat region (Cys1-Cys4) and C-terminal region (Cys8a, Cys8b, Cys8c) of MUC5B with statherin and histatins were investigated. These studies indicated that histatin 1 selectively bound to Cysl and Cys2, whereas statherin and histatin 1, 3, and 5 selectively bound to Cys8a. Analysis of the primary sequences of the identified binding domains suggests that these domains most probably can fold into globular-like structures in the native mucin. A ProDom blast search revealed that sequences in Cys1, Cys2, and Cys8a exhibit similarity to domains in evolutionarily diverse extracellular proteins known to participate in a wide variety of protein-protein interactions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10728974     DOI: 10.1177/00220345000790020601

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  9 in total

1.  Concentrated solutions of salivary MUC5B mucin do not replicate the gel-forming properties of saliva.

Authors:  Bertrand D E Raynal; Timothy E Hardingham; David J Thornton; John K Sheehan
Journal:  Biochem J       Date:  2002-03-01       Impact factor: 3.857

2.  Electron microscopic immunogold localization of statherin in human minor salivary glands.

Authors:  Michela Isola; Margherita Cossu; Denise Massa; Alberto Casti; Paola Solinas; Maria Serenella Lantini
Journal:  J Anat       Date:  2010-03-19       Impact factor: 2.610

Review 3.  Mucin-interacting proteins: from function to therapeutics.

Authors:  Shantibhusan Senapati; Srustidhar Das; Surinder K Batra
Journal:  Trends Biochem Sci       Date:  2009-11-11       Impact factor: 13.807

4.  Kinetics of histatin proteolysis in whole saliva and the effect on bioactive domains with metal-binding, antifungal, and wound-healing properties.

Authors:  Xiuli Sun; Erdjan Salih; Frank G Oppenheim; Eva J Helmerhorst
Journal:  FASEB J       Date:  2009-04-01       Impact factor: 5.191

5.  SIgA binding to mucosal surfaces is mediated by mucin-mucin interactions.

Authors:  Hannah L Gibbins; Gordon B Proctor; Gleb E Yakubov; Stephen Wilson; Guy H Carpenter
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

6.  Proteomic evaluation of acquired enamel pellicle during in vivo formation.

Authors:  Young Ho Lee; Jason N Zimmerman; William Custodio; Yizhi Xiao; Tayebeh Basiri; Sahza Hatibovic-Kofman; Walter L Siqueira
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

7.  Candida albicans Shed Msb2 and Host Mucins Affect the Candidacidal Activity of Salivary Hst 5.

Authors:  Sumant Puri; Justin Friedman; Darpan Saraswat; Rohitashw Kumar; Rui Li; Donna Ruszaj; Mira Edgerton
Journal:  Pathogens       Date:  2015-10-30

8.  In Vitro Identification of Histatin 5 Salivary Complexes.

Authors:  Eduardo B Moffa; Maria A A M Machado; Maria C M Mussi; Yizhi Xiao; Saulo S Garrido; Eunice T Giampaolo; Walter L Siqueira
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

Review 9.  Mucins in the mucosal barrier to infection.

Authors:  S K Linden; P Sutton; N G Karlsson; V Korolik; M A McGuckin
Journal:  Mucosal Immunol       Date:  2008-03-05       Impact factor: 7.313

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.